Lunit Receives FDA Approval for AI-Powered Breast Cancer Diagnostic Solution

South Korean-based Lunit, a leading provider of AI-based cancer diagnostics, has achieved a significant milestone by securing FDA 510(k) approval for its innovative Lunit INSIGHT DBT solution. This AI-powered medical device is designed to analyze 3D Breast Tomosynthesis (DBT) images, offering a promising advancement in breast cancer diagnosis. Revolutionizing breast cancer diagnosis Breast cancer is ... Read more